Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000622930 | SCV000741931 | uncertain significance | Inborn genetic diseases | 2016-11-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000655522 | SCV000777453 | uncertain significance | RYR1-related disorder | 2022-09-26 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 4296 of the RYR1 protein (p.Arg4296Trp). This variant is present in population databases (no rsID available, gnomAD 50%). This variant has not been reported in the literature in individuals affected with RYR1-related conditions. ClinVar contains an entry for this variant (Variation ID: 521376). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RYR1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Prevention |
RCV000721298 | SCV000852325 | uncertain significance | not provided | 2016-08-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000721298 | SCV001795630 | uncertain significance | not provided | 2022-11-16 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 20681998) |
MGZ Medical Genetics Center | RCV002289910 | SCV002581762 | uncertain significance | Central core myopathy | 2022-08-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002506516 | SCV002814315 | uncertain significance | Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome | 2021-07-26 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000655522 | SCV004035996 | uncertain significance | RYR1-related disorder | 2023-04-20 | criteria provided, single submitter | clinical testing | The RYR1 c.12886C>T (p.Arg4296Trp) missense variant has not, to our knowledge, been reported in the peer-reviewed literature. The highest frequency of this allele in the Genome Aggregation Database is 0.000641 in the African/African American population (version 3.1.2). This frequency is high for autosomal dominant inheritance but may be consistent with autosomal recessive inheritance. Based on the available evidence, the c.12886C>T (p.Arg4296Trp) variant is classified as a variant of uncertain significance for RYR1-related disorders. |